The freezer that does it allJuly 2019
The new freezer from BINDER – Reliable, energy-efficient and environmentally friendly
The new ULT freezer from BINDER, containing climate-neutral refrigerants, is an environmentally friendly choice that’s also highly energy-efficient. Ultra low temperature freezers (UF V) from the Tuttlingen-based company are able to cool their contents down to minus 80 degrees Celsius with ease and come equipped with climate-neutral refrigerants – both features that customers love.
The global warming potential (GWP) of both types of refrigerants that BINDER uses is negligibly low, at just three in the case of propane and six in the case of ethane. That’s compared to some freezers on the market whose refrigerants reach GWP values of as much as 13,400. What’s more, BINDER’s ultra low temperature freezers demonstrate extremely low energy consumption at only eight kilowatt hours per day – another figure that has users head over heels for these units. Most other models in the same class operate at up to 20 kilowatt hours per day, and some older versions can even go beyond this.
All these features are exactly why users are calling BINDER’s UF V freezers a reliable choice that delivers top standards of energy efficiency – and why many industry experts have even named them the best in their class. Simply put, BINDER’s new freezer units and their green refrigerants deliver impressive performance in every way. And if users are keen to be even more environmentally conscious in their use of resources, they can opt for the version with a water cooling function in order to use the waste heat for applications such as room heating.
Yet another useful feature is the combination of an electromechanical door lock and a numerical pad, which make it extremely easy to open and electronically lock the freezer. All of these benefits add up to a BINDER freezer that’s innovative, energy-efficient, environmentally friendly, and – most importantly – versatile.
That’s why UF V units are so frequently found in research applications, biobanks, and pharmaceutical production.